MedTrace Logo

Pediatric Asthma Controller Trial (PACT)

NCT00272506 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-07-12

No results posted yet for this study

Summary

To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

Conditions

Interventions

DRUG

inhaled corticosteroid

DRUG

long-acting beta2-agonist

Sponsors & Collaborators

  • Childhood Asthma Research and Education Network

    collaborator NETWORK

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Vernon Chinchilli · Milton S. Hershey Medical Center

  • Robert Lemanske · University of Wisconsin, Madison

  • Fernando Martinez · University of Arizona

  • Robert Strunk · Washington University School of Medicine

  • Stanley Szefler · National Jewish Health

  • Robert Zeiger · University of California, San Diego

Study Design

Purpose
TREATMENT
Model
CROSSOVER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Completion
2004-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00272506 on ClinicalTrials.gov